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Abstract
Objectives The aim of this study was to assess gingival fluid
(GCF) cytokine messenger RNA (mRNA) levels, subgingi-
val bacteria, and clinical periodontal conditions during a
normal pregnancy to postpartum.
Materials and methods Subgingival bacterial samples were
analyzed with the checkerboard DNA–DNA hybridization
method. GCF samples were assessed with real-time PCR
including five proinflammatory cytokines and secretory leu-
kocyte protease inhibitor.
Results Nineteen pregnant women with a mean age of
32 years (S.D. ± 4 years, range 26–42) participated in the
study. Full-mouth bleeding scores (BOP) decreased from an
average of 41.2% (S.D. ± 18.6%) at the 12th week of
pregnancy to 26.6% (S.D. ± 14.4%) at the 4–6 weeks post-
partum (p<0.001). Between week 12 and 4–6 weeks post-
partum, the mean probing pocket depth changed from
2.4 mm (S.D. ± 0.4) to 2.3 mm (S.D. ± 0.3) (p00.34).
Higher counts of Eubacterium saburreum, Parvimonas
micra, Selenomonas noxia, and Staphylococcus aureus were
found at week 12 of pregnancy than at the 4–6 weeks
postpartum examinations (p<0.001). During and after preg-
nancy, statistically significant correlations between BOP
scores and bacterial counts were observed. BOP scores
and GCF levels of selected cytokines were not related to
each other and no differences in GCF levels of the cytokines
were observed between samples from the 12th week of
pregnancy to 4–6 weeks postpartum. Decreasing postpartum
counts of Porphyromonas endodontalis and Pseudomonas
aeruginosa were associated with decreasing levels of Il-
8 and Il-1β.
Conclusions BOP decreased after pregnancy without any
active periodontal therapy. Associations between bacterial
counts and cytokine levels varied greatly in pregnant wom-
en with gingivitis and a normal pregnancy outcome. Post-
partum associations between GCF cytokines and bacterial
counts were more consistent.
Clinical relevance Combined assessments of gingival fluid
cytokines and subgingival bacteria may provide important
information on host response.
Keywords Pregnancy . Bacteria . Cytokine . Gingival
inflammation . Gingival crevicular fluid
Introduction
During pregnancy, gingival inflammation is common. Preg-
nancy gingivitis usually resolves spontaneously within a
few weeks after delivery [1–3]. Data suggest that temporary
clinical periodontal changes during pregnancy do not result
in an increased risk for future periodontitis [4]. During the
second trimester of pregnancy, a shift of the subgingival
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levels of Prevotella intermedia and Porphyromonas gingi-
valis has been observed [2, 5, 6]. Other authors have not
found any differences in the composition of the oral biofilm
between pregnant and nonpregnant women [4, 7]. Why
within a few weeks after delivery, increased gingival inflam-
mation during pregnancy is quickly resolved, remains un-
clear. In a previous publication including the same subjects
as in the present work, we identified that bacterial counts of
bacteria associated with periodontitis did not change during
pregnancy or to a time point at 4–6 weeks postpartum [8].
Recent data suggest that cytokine levels in saliva may be
linked to the periodontal status [9]. Other studies have not been
able to demonstrate that salivary levels of granulocyte–macro-
phage colony-stimulating factor (GM-CSF), interleukin-1β
(IL-1β), interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-
5 (IL-5), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-
10 (IL-10), interferon-g (IFN-g), and tumor necrosis factor-α
(TNF-α) can discriminate between periodontal health and
disease [10].
Studies of cytokine levels in gingival crevicular fluid
(GCF) have suggested that TNF-α levels are lower at
healthy sites in periodontally healthy subjects than in sub-
jects with advanced periodontitis, who have high levels of
TNF-α in GCF both at sites with or without evidence of
disease [11]. The influence of sex hormones on proinflam-
matory cytokines in GCF of healthy premenopausal, non-
pregnant women has recently been studied. No associations
between clinical periodontal parameters, hormonal changes,
and differences in GCF cytokine levels were found [12]. In a
study with pregnant women, exacerbated gingival inflam-
mation during pregnancy could not be associated with in-
creased salivary progesterone or estradiol levels or increased
levels of proinflammatory cytokines [13].
Secretory leukocyte protease inhibitor (SLPI) is present in
human fluids and also in gingival tissues [14]. SLPI is a
common antimicrobial protein of the upper airways [15] inhib-
iting LPS and nuclear factor-κB (NF-κB) activation [16]. SLPI
exhibiting strong antibacterial activities has been identified in
GCF [17]. Furthermore, SLPI causes an upregulation of the
production of anti-inflammatory cytokines [18]. In vitro studies
have, however, also recently demonstrated that arginine-
specific gingipains of P. gingivalis inhibit the protective effects
of SLPI [14]. Currently, it is unknown if GCF levels of SLPI
change during pregnancy, or if the presence or absence of oral
bacteria influences the GCF levels of SLPI in pregnancy.
Up to date, we have only limited information about the
relationship between bacteria in periodontal pockets/sulci
and the presence or absence of proinflammatory cytokines
in pregnant women. Therefore, the purposes of the present
study were to assess:
1. Microbiological changes between week 12 of pregnancy
to 4–6 weeks postpartum and in relation to changes in
gingival inflammation (percent sites with bleeding on
probing (BOP)) between week 12 of pregnancy and 4–
6 weeks postpartum
2. The association between levels of mRNA of proinflam-
matory cytokines in gingival fluid and the severity of
gingival inflammation (percent sites with BOP) at week
12 of pregnancy and 4–6 weeks postpartum
3. Differences in GCF cytokine levels of mRNA (IL-1α,
IL-1β, IL-8, TNF-α, and SLPI) at the 12th week of
pregnancy and 4–6 weeks postpartum
4. The association between changes in bacterial and cyto-
kine levels between week 12 of pregnancy and 4–6 weeks
postpartum
Materials and methods
The Institutional Review Board of the Cantons of Jura,
Fribourg, and Neuchâtel, Switzerland approved the present
study. All the participating subjects signed informed consent.
The study was a prospective consecutive case series over the
period of pregnancy (from week 12 through 4–6 weeks
postpartum) without study-defined medical or dental
interventions.
Subject population
Pregnant women, 18 years of age or older, attending the
Department of Obstetrics and Gynecology at the State
Hospital of Fribourg, Switzerland and with singleton
pregnancy were included. Women with known congen-
ital uterine malformations, congenital vaginal malforma-
tions, fetal malformation, multifetal gestation, and with
chronic diseases (e.g., diabetes, hypertension, epilepsy,
cardiac disease, lung disease, renal disease, and positive
test for human immunodeficiency virus (HIV)) were
excluded. All the participating women were monitored
by standard of care principles at the Department of
Obstetrics and Gynecology. The subjects were recruited
between April and October 2006. None of the women
had received periodontal therapy before and during
pregnancy.
GCF sampling and processing
GCF was collected with sterile endodontic paper points
(absorbent paper points, Dentsply/Maillefer, Ballaigues,
Switzerland), and parallel to this procedure, subgingival
bacterial samples were also collected using sterile endodon-
tic paper points. GCF and subgingival bacterial samples
were harbored from the mesiobuccal aspects of all first
molars, and each paper point remained in situ for 15 s.
The first molars were chosen while these teeth are
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commonly present in young adults and evidence of inflam-
mation at these teeth are common. In addition, the first
molars are simple to isolate and easy to collect samples
from. The samples were placed in separate Eppendorf tubes
(1.5 ml natural flat cap microcentrifuge tubes, Starlab,
Ahrensburg, Germany) for the assessment of cytokines and
bacteria. All the samples were immediately transported on
dry ice to the Oral Microbiology Laboratory of the Univer-
sity of Bern, Switzerland for processing.
Clinical examination
A full-mouth periodontal examination with the assess-
ments of BOP and probing pocket depth (PPD) was
performed at the 12th week of pregnancy and at a visit
4–6 weeks after delivery. BOP, PPD, and gingival reces-
sion were measured at six sites per tooth using the
Florida probe® system (Florida Probe Corporation, Gain-
esville, FL, USA) with a standardized pressure of
0.15 N. The same examiner (L. A.) performed the peri-
odontal measurements. Gingivitis was defined as having
>20% of sites with BOP if periodontitis was not found.
Periodontitis was defined as having periodontal sites with
probing pocket depths >4 mm and with radiographic
evidence of alveolar bone loss as defined from post
pregnancy intraoral radiographs.
Analysis of subgingival bacterial samples
The bacterial samples were stored at −20°C and processed
after a standard storage period of 3 months. To each
sample, 0.15 ml TE (10 mM Tris–HCL, 1 mM EDTA,
pH 7.6) and 0.5 ml NaOH were added. All the bacterial
samples were analyzed with the checkerboard DNA–DNA
hybridization technique. The 74 species assessed are pre-
sented in Table 1. The checkerboard DNA–DNA hybrid-
ization was performed as described elsewhere [19, 20].
Briefly, bacterial DNA was extracted using the method of
Smith et al. [21], concentrated on nylon membranes
(Roche Diagnostics GmbH, Mannheim, Germany), and
fixed by cross-linking using ultraviolet light (Stratalinker
1800, Stratagene, La Jolla, CA, USA). The membranes
with fixed DNA were placed in a Miniblotter 45 (Immu-
nitics, Cambridge, MA, USA). Signals were detected by
fluorescence using the Storm Fluor-Imager (Storm 840,
Amersham Biosciences, Piscataway, NJ, USA) with a
setup of 200 μm and 600 V. The digitized information
was analyzed by a software program (ImageQuant,
Amersham Pharmacia, Piscataway NJ, USA), allowing
comparison of the density of the 19 sample lanes against
the 2 standard lanes (105 or 106 cells). Signals were
converted to absolute counts by comparisons with these
standards [19]. Subject-based mean values for bacterial
counts of these species were calculated and used in the
assessments.
GCF analysis of cytokines
RNA extraction
The GCF samples were frozen at −79°C. After thawing, the
lysis buffer (RNAqueous®-Micro kit, Ambion, Austin, TX,
USA) was added to the Eppendorf tube for 10 min. EtOH
100% was added, and the mixture was loaded on the Micro
Filter Cartridge assembly (RNAqueous®-Micro kit, Ambion,
Austin, TX, USA). Further processing was performed accord-
ing to manufacturer's instructions. The eluted RNAwas trea-
ted with DNAse 1 (RNAqueous®-Micro kit, Ambion, Austin,
TX, USA).
Reverse transcription and quantitative real-time polymerase
chain reaction
The total RNA used for quantitative real-time polymerase
chain reaction (QRT-PCR) was reversely transcribed using
random primers and MultiScribe™ reverse transcriptase
according to manufacturer's instructions (high-capacity
cDNA reverse transcription kit, Applied Biosystems, Fos-
ter City, CA, USA). Transcribed reactions were analyzed
in real-time on an ABI 7500 (Applied Bio Systems, Foster
City, CA, USA) using TaqMan® Universal PCR Master
Mix (Applied Biosystems, Foster City, CA, USA). Primers
and probes for detection of cytokines were all purchased
from Applied Biosystems. Thermal cycling parameters
were 50°C for 2 min, 95°C for 10 min, followed by 40
cycles of 95°C for 30 s and 60°C for 1 min. Reactions
were performed in triplicates and threshold cycle numb-
ers were averaged. The threshold data generated were
normalized to GAPDH and UBB, calculating Δct. These
housekeeping genes were chosen after analyzing 10 dif-
ferent endogenous controls with 12 GCF samples. The
amount of cDNA was standardized for all reactions. The
samples were collected from 12 different randomly selected
nonpregnant individuals and therefore not part of the study
(data not shown).
Statistical methods
Statistical analysis was performed using Wilcoxon signed
rank test for within subject changes over time. Mann–
Whitney U tests were also used to assess changes over
time. Correlation coefficients between parameters were
assessed by Pearson correlation coefficient. Analysis by
linear (stepwise) regression was performed to identify
explanatory models to GCF cytokine changes during
pregnancy.
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Results
The mean age of the 19 women, who all delivered a child
without complications, was 32 years (S.D. ± 4 years, range
26–42). Clinical periodontal conditions during the pregnan-
cies have been reported elsewhere [8]. Briefly, and at the
12th week of pregnancy, 1.5% of sites (six sites per tooth
examined) had a PPD >4 mm which changed to 1.4% at the
Table 1 Bacteria included in the checkerboard DNA–DNA hybridization assays
Bacteria Collection Bacteria Collection
Aggregatibacter actinomycetemcomitans (a) ATCC29523 Actinomyces neuii GUH550898
Aggregatibacter actinomycetemcomitans (Y) ATCC43718 Aerococcus christensenii GUH070938
Actinomyces israelii ATCC 1201 Anaerococcus vaginalis GUH290486
Actinomyces naeslundii ATCC121045 Atopobium parvulum GUH160323
Actinomyces odontolyticus ATCC17929 Atopobium vaginae GUH010535
Capnocytophaga gingivalis ATCC33612 Bacteroides ureolyticus GUH080189
Capnocytophaga ochracea ATCC33596 Bifidobacterium biavatii GUH071026
Capnocytophaga sputigena ATCC33612 Bifidobacterium bifidum GUH070962
Campylobacter gracilis ATCC33236 Bifidobacterium breve GUH080484
Campylobacter rectus ATCC33238 Bifidobacterium longum GUH180689
Campylobacter showae ATCC451146 Corynebacterium nigricans GUH450453
Eikenella corrodens ATCC238345 Corynebacterium aurimucosum GUH071035
Eubacterium saburreum ASTCC33271 Dialister sp. GUH071035
Fusobacterium nucl. naviforme ASTCC49256 Enterococcus faecalis GUH170812
Fusobacterium.nucl.nucleatum ATCC25586 Enterococcus faecalis ATCC29212
Fusobacterium.nucl. polymorphum ATCC10953 Echerichia coli GUH070903
Fusobacterium periodonticum ATCC33993 Gardnerella vaginalis GUH080585
Lactobacillus acidophilus ATCC11975 Haemophilus influenzae ATCC49247
Leptothrichia buccalis ATCC14201 Helicobacter pylori ATCC43504
Neisseria mucosa ATCC33270 Lactobacillus crispatus GUH160342
Parvimonas micra ATCC19696 Lactobacillus gasseri GUH170856
Prevotella intermedia ATCC25611 Lactobacillus iners GUH160334
Prevotella melaninogenica ATCC25845 Lactobacillus jensenii GUH160339
Prevotella nigrescens ATCC33563 Lactobacillus vaginalis GUH0780928
Porphyromonas gingivalis ATCC33277 Mobiluncus curtisii GUH070927
Propionybacterium acnes ATCC11827/28 Mobiluncus mulieris GUH070926
Selenomonas noxia ATCC43541 Peptoniphilus sp. GUH550970
Streptorcoccus anginosus ATCC33397 Peptostreptococcus anaerobius GUH160362
Streptococcus constellatus ATCC27823 Porphyromonas endodontalis ATCC35406
Streptococcus gordonii ATCC10558 Prevotella bivia GUH450429
Streptococcus intermedius ATCC27335 Prevotella disiens GUH190184
Streptococcus mitis ATCC49456 Proteus mirabilis GUH070918
Streptococcus mutans ATCC25175 Pseudomomas aeruginosa ATCC33467
Streptococcus oralis ATCC35037 Staphylococcus aureus ATCC25923
Streptococcus sanguinis ATCC10556 Staphylococcus.aureus yellow strain GUH070921
Tannerella forsythia ATCC43037 Staphylococcus aureus white strain GUH070922
Treponema denticola ATCC354405 Staphylococcus epidermis DSMZ20044
Treponema socranskii D40DR2 Staphylococcus haemolyticus DSMZ20263
Veillonella parvula ATCC10790 Streptococcus agalactiae GUH230282
Varibaculum cambriense GUH070917
ATCC American type culture collection, D sample from Forsyth Institute, Boston, MA, USA, GUH Ghent University Hospital Collection, Ghent,
Belgium
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4–6 weeks postpartum examination. At week 12, the mean
PPD was 2.4 mm (S.D. ± 0.4). At 4–6 weeks postpartum,
the mean PPD was 2.3 mm (S.D. ± 0.3) (p00.34). Evidence
of gingival hyperplasia was found at 8.7% of sites at the
12th week of pregnancy and at 9.1% at 4–6 weeks postpar-
tum. On average, these women had 29 teeth (S.D. ± 1.5). A
clinical diagnosis of gingivitis was made in all of the 19
subjects. None of the subjects could be identified as having
periodontitis. A decrease in BOP scores from a mean of
41.2% (S.D. ± 18.6%) at week 12 of pregnancy to 26.6% (S.
D. ± 14.4%) at the 4–6 weeks postpartum examination was
found (p<0.001). The proportion of sites with BOP at week
12 was significantly correlated with the proportion of sites
with BOP at 4–6 weeks postpartum (r00.73, p<0.001)
(Fig. 1).
Microbiological changes between week 12 of pregnancy
to 4–6 weeks postpartum and in relation to changes in gingival
inflammation (in percent, sites with BOP) between week
12 of pregnancy and 4–6 weeks postpartum
The distributions of selected bacteria are presented (Table 2).
At week 12, as well as at the 4–6 weeks postpartum exami-
nations, no differences in bacterial counts were found be-
tween women with a diagnosis of gingivitis or periodontitis,
respectively. Thus, independent of the periodontal diagno-
sis, the following microorganisms were found at significant-
ly higher counts at week 12 than at the microbiological
sampling 4–6 weeks postpartum: Eubacterium saburreum,
Parvimonas micra, Selenomonas noxia, and Staphylococcus
aureus (p<0.001). Mobiluncus curtisii presented with the
opposite pattern. The changes for S. aureus and P. micra are
presented in Fig. 2.
The subject-based proportions of BOP scores at week 12 of
pregnancy were significantly correlated with the bacterial
counts of Actinomyces israelii (r00.62, p00.006), Actinomy-
ces naeslundii (r00.56, p00.012), Actinomyces odontolyticus
(r00.61, p00.006), Bifidobacterium bifidum (r00.61,
p00.006), Lactobacillus acidophilus (r00.60, p00.006),
Treponema socranskii (r00.61, p00.006), and P. gingivalis
(r00.56, p00.012).
At 4–6 weeks postpartum, statistically significant correla-
tions between the BOP scores and the bacterial counts were
found for: Actinomyces neuii (r00.57, p<0.01), Atopobium
parvulum (r00.61, p00.006), Bifidobacterium biavatii
(r00.61, p00.006), B. bifidum (r00.71, p00.001), Bifidobac-
terium breve (r00.71, p00.001),Corynebacterium aurimuco-
sum (r00.70, p00.001), Corynebacterium nigricans (r00.63,
p00.001), Enterococcus faecalis (r00.63, p00.003), M.
Fig. 1 Scatterplot diagram illustrating the relationship between per-
cent BOP scores at week 12 of pregnancy and percent BOP scores at
4–6 weeks postpartum
Table 2 Frequency distribution (in percent) of selected bacteria at
week 12 and at 4–6 weeks postpartum at 104 and 105 bacterial cell
cutoff levels
Week 12 4-6 weeks post-partum
104 cells 105 cells 104 cells 105 cells
E. saburreum 100.0 5.3 100.0 0.0
M. curtisii 5.3 0.0 43.1 9.0
P. micra 100.0 5.3 84.0 0.0
S. noxia 100.0 10.5 73.7 5.3
S. aureus 100.0 36.8 89.5 5.3
Fig. 2 Boxplot diagram illustrating the levels of S. aureus and P.
micra at week 12 of pregnancy and 4–6 weeks postpartum. X-axis0
1.0×105 bacterial cells; circles with different colors outlier values
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curtisii (r00.68, p00.001), Mobiluncus mulieris (r00.71,
p00.001), P. intermedia (r00.62, p00.005), Pseudomonas
aeruginosa (r00.002, p00.001), Tannerella forsythia
(r00.59, p00.008), Streptococcus agalactiae (r00.58,
p00.007), Treponema denticola (r00.89, p00.001), and T.
socranskii (r00.61, p00.006).
The significant correlations between changes in bacterial
levels are presented (Table 3). The highest level of a corre-
lation in bacterial counts between week 12 of pregnancy and
4–6 weeks postpartum was identified between changes of
Porphyromonas endodontalis and P. aeruginosa (r00.99,
p<0.001).
Association between levels of mRNA of proinflammatory
cytokines in gingival fluid and the severity of gingival
inflammation (in percent, sites with BOP) at week 12
of pregnancy and 4–6 weeks postpartum
Neither at the week 12, nor at the 4–6 weeks post-partum
examinations were BOP scores correlated with cytokine
values.
Differences in GCF cytokine levels of mRNA (IL-1α, IL-1β,
IL-8, TNF-α, and SLPI) at the 12th week of pregnancy
and 4–6 weeks postpartum
At week 12, as well as at the 4–6 weeks postpartum exam-
ination, no differences in the GCF mRNA cytokine levels
studied were found between women with a diagnosis of
gingivitis or periodontitis. Thus, with all cases, included
statistical analysis failed to demonstrate differences in
GCF levels of mRNA: IL-1α, IL-1β, IL-8, TNF-α, and
SLPI between samples from the 12th week of pregnancy
and 4–6 weeks postpartum.
GCF levels of mRNA IL-8 were significantly correlated
with mRNA IL-1β levels (r00.80, p<0.001). GCF levels of
mRNA IL-8 were also correlated with mRNATNF-α levels
(r00.63, p00.003).
The GCF levels of mRNA SLPI at both the 12th week of
pregnancy and at the 4–6 weeks postpartum assessments
were significantly correlated with GCF levels of MRNA
IL-1α (r00.49, p<0.001), (r00.69, p00.001), respectively.
The reverse relationship between the changes in mRNA
SLPI and mRNA Il-1α between week 12 and 4–6 weeks
postpartum (r0−0.71, p<0.01) is presented in a scatterplot
diagram (Fig. 3). GCF levels of mRNA IL-8 and mRNA IL-
1β were correlated with mRNA TNF-α levels (r00.66,
p00.002) and (r00.66, p<0.002) and correlated with the
GCF levels of mRNA IL-1α (r0−0.71, p<0.001), respec-
tively. The changes in the levels of mRNA IL-8 and
mRNA IL-1β between week 12 of pregnancy and the
4–6 week postpartum assessments were also significantly
correlated (r0−0.88, p<0.001). Statistical analysis failed to
demonstrate correlations between changes in levels of the
other cytokine combinations. Data on the mRNA TNF-α
levels, mRNA Il-8, mRNA Il-1β, and SLPI at week 12 and
4–6 weeks postpartum are presented in a boxplot diagram
(Fig. 4).
The association between changes in bacterial and cytokine
levels between week 12 of pregnancy and 4–6 weeks
postpartum
Statistically significant correlations between changes in bac-
terial counts at 12 weeks of pregnancy and postpartum are
presented (Table 4). Decreasing levels of P. endodontalis
and P. aeruginosa were correlated with decreasing levels of
mRNA Il-8 and mRNA Il-1β. Decreasing levels of Bacter-
oides ureolyticus were correlated with decreasing expres-
sion of mRNA Il-1α (r00.48, p<0.05). It was noticeable
that no correlations in changes in cytokine expression and
bacterial changes were found for bacteria associated with
periodontitis (P. gingivalis, T. forsythia, and T. denticola).
Table 3 Significant correlations between changes in subgingival counts of bacteria between week 12 of pregnancy and 4–6 weeks postpartum
A. neuii A. parvula B. biavatii E. faecalis M. curtisii P. aeruginosa P. micra P. endodontalis S. aureus S. agalactiae
A. neuii 0.61*** 0.62*** 0.63***
A. parvula 0.85*** 0.83*** 0.52* 0.81***
B. biavatii 0.95*** 0.56** 0.87***
E. faecalis 0.83*** 0.46* 0.85***
M. curtisii 0.61*** 0.52* 0.56** 0.46* 0.73*** 0.71***
P. aeruginosa 0.62*** 0.73*** 0.99*** 0.64***
P. micra 0.67***
P. endodontalis 0.63*** 0.71*** 0.99*** 0.60**
S. aureus 0.67***
S. agalactiae 0.81*** 0.87*** 0.85*** 0.64*** 0.60**
*p<0.05; **p<0.01; ***p<0.001
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Explanatory variables to cytokine levels at week 12
and 4–6 weeks postpartum
GCF levels of mRNA IL-8 and mRNA IL-1β were explained
by bacterial counts of P. endodontalis (t03.4, p<0.05), (t04.6,
p<0.001), respectively. GCF levels of mRNA IL-1α were
explained by bacterial counts of B. ureolyticus (t05.7,
p<0.001). High GCF levels of mRNA SLPI were associated
with low counts of P. aeruginosa (t0−3.1, p<0.001). GCF
levels of mRNATNF-α could not be explained by any of the
counts of microorganisms studied.
Discussion
In the present study, pregnant women with a normal preg-
nancy outcome consecutively admitted to an obstetrics and
gynecology ward were examined. The subject sample size in
the present study was small but comparable to several other
studies that have assessed specific factors in relation to
pregnancy and periodontal conditions. One of the difficul-
ties in assessing periodontal status during pregnancy can be
the absence of radiographic evidence of bone loss or the
interpretation of bone levels. Another problem may be the
rather common finding of gingival hyperplasia that was
found in 9% of the subjects in the present study. When we
applied the same criteria as those used by Novak et al. 2008
[22] to the subjects in the present study all the pregnant
women were diagnosed as only having gingivitis at both the
12th week and at the postpartum examination. The alveolar
bone levels as assessed from available radiographs were
within normal limits as was expected in this age cohort
and clinical presentation.
Others have reported that approximately 40% to 50% of
pregnant women have gingivitis [23]. In the present study
population, the mean extent of BOP was 41.2% at 12 weeks
of pregnancy. Although all subjects with no influence by the
investigators had abstained from professional dental care
during the pregnancy, the BOP scores decreased to, on
average, 26.6% at 4–6 weeks postpartum. The decrease in
the extent of gingival inflammation could be the result of a
physiological change, which may be explained by hormonal
changes during pregnancy [2, 24]. This would then also
suggest that the hormonal changes may have an impact on
mRNA cytokine expression in gingival tissues and fluids,
while maintaining a balanced bacterial biofilm. In a recent
study, data suggested that in premenopausal women only
GCF levels of mRNA IL-6 levels peaked at the time of
Table 4 Statistically significant correlation coefficients between
changes in cytokine and bacterial counts
IL-1α IL-1β IL-8 TNF-α
B. ureolyticus −0.48*
C. aurimucosum 0.47*
M. curtisii −0.51* −0.57**
M. mulieris −0.61*** −0.69***
P. aeruginosa −0.47** −0.54*
P. endodontalis −0.52* −0.58*
S. agalactiae −0.50*
*p<0.05; **p<0.01; ***p<0.001 (Pearson's correlation)
Fig. 3 Scatterplot diagram illustrating the relationship between
changes in mRNA SLPI and mRNA IL-1α between week 12 of
pregnancy and the 4–6 weeks postpartum analysis
Fig. 4 Boxplot diagram illustrating mRNA cytokine levels at week 12
and at 4–6 weeks postpartum (empty circles represent outlier values and
asterisks represents extreme outliers. Whiskers represent 25th and 75th
percentiles)
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ovulation. This was not accompanied by clinical changes in
the extent of gingival inflammation [25]. These authors
failed to show changes in GCF levels of other proinflamma-
tory cytokines during a normal menstrual cycle. Thus the
impact of hormonal changes on gingival inflammation is
unclear. In the present study, the change in mean PPD
between week 12 and 4–6 weeks postpartum was statisti-
cally not significant and also clinically irrelevant. This may,
in part explain the results obtained in regards to GCF
changes in cytokines and bacterial counts.
The scientific evidence in regard to the subgingival
microbiota during pregnancy in regard to bacterial counts
is inconsistent [2, 4–7]. This may, in part, be the result of
differences in sampling methods and analysis, diagnostic
criteria, treatment provided or not, age of the pregnant
subjects, general health status, and, i.e., smoking habits.
The observations in the present study suggested that the
microbiota assessed overall was stable between the 12th
week of pregnancy and until 4–6 weeks postpartum some
species would suggest that hormonal changes may not result
in microbiological shifts.
The present study also identified that the extent of BOP
both at week 12 of pregnancy and at 4–6 weeks postpartum
was associated with a complex microbiota dominated by
bacteria associated with gingivitis. Significantly higher counts
of E. saburreum, P. micra, S. noxia, and S. aureus were,
however, found at week 12 of pregnancy than at the 4–6 week
postpartum examination, suggesting a decrease for these spe-
cies. In contrast M. curtisii increased from week 12 of preg-
nancy to 4–6 week postpartum. E. saburreum,M. curtisii, and
S. noxia are commensal oral bacteria, whileP. micra is a gram-
positive, anaerobic bacterium and has been associated with
periodontal destruction [26]. S. aureus infection has been
associated with periodontitis [27] but is also found in periodon-
tally healthy subjects. It is noticeable that the counts of bacteria
commonly associated with periodontitis did not change during
the study period. The overall stable oral microbiota noticed in
the present study is consistent with the perception of a stable
vaginal microbiota during normal pregnancies and in the ab-
sence of bacterial vaginosis.
The inclusion of a study method to assess mRNA cyto-
kine levels in GCF was made based on a common principle
to assess various enzymes in GCF and primarily expressed
by immune competent cells, i.e., polymorphonuclear cells
(PMN cells). PMN cells constitute a major component of the
cellular component in GCF.
No differences in mRNA detected in GCF for IL-1α, IL-
1β, IL-8, TNF-α, and SLPI between week 12 and postpartum
were found. Thus, the changes in gingival inflammation
(BOP) may only weakly be associated with the expression
of these selected cytokines in GCF during pregnancy.
In the present study, consistent correlations between the
levels of mRNA: IL-1β, TNF-α, and IL-8 during pregnancy
and postpartum were identified. IL-1β and TNF-α are po-
tent proinflammatory cytokines. IL-1β induces chemotaxis
of leukocytes by inducing the production of IL-8 [28].
During pregnancy, there is a decrease in B cell response
due to progressive increase of progesterone and estrogens,
which reaches the peak in the third trimester [29]. P. endo-
dontalis LPS is capable of stimulating PMNs to produce
chemotactic cytokines [30]. In the present study, an upregu-
lation of IL-8 and IL-1β was associated with higher levels
of P. endodontalis.
Information about the relationship between bacteria in
periodontal pockets/sulci and presence or absence of proin-
flammatory cytokines is limited. This may partly be
explained by difficulties to accurately assess levels of proin-
flammatory cytokines in GCF. The use of a high-capacity
cDNA reverse transcription method using housekeeping
genes as standard references and to use gene expression to
quantify cytokines [31, 32] in relation periodontal inflam-
mation and bacterial presence during pregnancy might over-
come this problem.
SLPI is a neutrophil elastase inhibitor with antibacterial
and with anti-inflammatory properties [33]. While SLPI is
associated with antibacterial and anti-inflammatory condi-
tions, IL-1α suggests an early phase of inflammation. In the
present study a significant correlation was found between
the changes in GCF levels of SLPI and IL-1α both at week
12 of pregnancy and postpartum. The period between the
12th week of pregnancy and the postpartum examination
may therefore reflect a transient phase of inflammation in
pregnant/post-delivery women.
In the present study, the levels of the SLPI cytokine were
inversely correlated with counts of P. aeruginosa but only
postpartum. P. aeruginosa is a known pathogen in chronic
infections and identified in periodontitis [34] High counts of
SLPI are consistent with low counts of pathogens, which is
consistent with periodontal conditions postpartum in the
women participating in the present study.
In gingival inflammation, GCF is secreted by and
through the sulcular epithelium and this exudate is rich in
cellular elements specifically leucocytes, primarily neutro-
phils, and lymphocytes. Bacterial stimuli induce production
of proinflammatory cytokines facilitating the host immune
system to control the infectious agents. Data suggest that the
levels of cytokines in GCF are associated with periodontal
disease status [35]. However bacteria, i.e., P. gingivalis can
modulate important host signaling cytokine responses [36].
In the present study, we assessed mRNA expression of
proinflammatory cytokines and the SLIPI while accounting
for bacterial presence in GCF. The lack of agreement be-
tween bacterial levels in GCF and the assessments of cyto-
kine messenger mRNA identified in the present study may
reflect the imbalance in the abilities between host and in-
fectious agents which was also reflected by gingival status
26 Clin Oral Invest (2013) 17:19–28
in pregnant women. It might be that the primary line of host
defense is not in GCF but in gingival tissues and where the
mRNA expression of cytokines through competent immune
cells prevent bacteria invasion.
To conclude, BOP decreased between the week 12 of
pregnancy and postpartum. Therefore, moderate gingivitis
during pregnancy may partially resolve without any active
therapy. GCF levels of proinflammatory cytokines were cor-
related with each other. Specifically decreasing expression of
proinflammatory cytokines and levels of some bacteria (i.e.,
B. ureloyticus, P. aeruginosa, and P. endodontalis) appears to
be explanatory to clinical periodontal improvements 4–
6 weeks postpartum. However, we were unable to explain
the difference in susceptibility to pregnancy gingivitis with
elevated proinflammatory cytokine levels during pregnancy.
In the future, studies with larger populations are needed in this
field of research.
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